Literature DB >> 19619755

Vascular perfusion abnormalities in infants with spinal muscular atrophy.

Alexandra prufer de Queiroz Campos Araujo1, Mario Araujo, Kathryn J Swoboda.   

Abstract

Spinal muscular atrophy (SMA) is an important cause of death in children and SMA type I, also known as Werdnig-Hoffman disease, is the most severe form of this disease. We report 2 cases of infants with SMA I in whom a distal necrosis developed, a feature not previously reported. Poor perfusion, autonomic dysfunction, and position-dependent factors may all play a role in the development of this complication.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19619755      PMCID： PMC3250227          DOI： 10.1016/j.jpeds.2009.01.071

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


  13 in total

1.  Baroreflex control of muscle sympathetic nerve activity after 120 days of 6 degrees head-down bed rest.

Authors:  A Kamiya; S Iwase; H Kitazawa; T Mano; O L Vinogradova; I B Kharchenko
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2000-02       Impact factor: 3.619

2.  Finger cold-induced vasodilatation, sympathetic skin response, and R-R interval variation in patients with progressive spinal muscular atrophy.

Authors:  Hidee Arai; Yuzo Tanabe; Yasuo Hachiya; Eiko Otsuka; Satoko Kumada; Wakana Furushima; Jun Kohyama; Sumimasa Yamashita; Jun-ichi Takanashi; Yoichi Kohno
Journal:  J Child Neurol       Date:  2005-11       Impact factor: 1.987

3.  Decreased heart rate variability in amyotrophic lateral sclerosis.

Authors:  F Pisano; G Miscio; G Mazzuero; P Lanfranchi; R Colombo; P Pinelli
Journal:  Muscle Nerve       Date:  1995-11       Impact factor: 3.217

4.  Sympathetic skin response abnormalities in amyotrophic lateral sclerosis.

Authors:  C Dettmers; D Fatepour; H Faust; F Jerusalem
Journal:  Muscle Nerve       Date:  1993-09       Impact factor: 3.217

Review 5.  VEGF at the neurovascular interface: therapeutic implications for motor neuron disease.

Authors:  Diether Lambrechts; Peter Carmeliet
Journal:  Biochim Biophys Acta       Date:  2006-05-09

6.  Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia.

Authors:  Vanessa D Marques; Amilton A Barreira; Mary B Davis; Patrick M Abou-Sleiman; Wilson A Silva; Marco A Zago; Claudia Sobreira; Valéria Fazan; Wilson Marques
Journal:  Muscle Nerve       Date:  2006-12       Impact factor: 3.217

7.  A comparison of the structure of small blood vessels in normal, denervated and dystrophic human muscle.

Authors:  B C Musch; T A Papapetropoulos; D A McQueen; P Hudgson; D Weightman
Journal:  J Neurol Sci       Date:  1975-10       Impact factor: 3.181

8.  Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition.

Authors:  Heather L Narver; Lingling Kong; Barrington G Burnett; Dong W Choe; Marta Bosch-Marcé; Addis A Taye; Michael A Eckhaus; Charlotte J Sumner
Journal:  Ann Neurol       Date:  2008-10       Impact factor: 10.422

9.  Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1).

Authors:  S Rudnik-Schöneborn; P Stolz; R Varon; K Grohmann; M Schächtele; U-P Ketelsen; D Stavrou; H Kurz; C Hübner; K Zerres
Journal:  Neuropediatrics       Date:  2004-06       Impact factor: 1.947

10.  The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis.

Authors:  H Takahashi; K Oyanagi; F Ikuta
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088
View more
  58 in total

1.  Motor neuron rescue in spinal muscular atrophy mice demonstrates that sensory-motor defects are a consequence, not a cause, of motor neuron dysfunction.

Authors:  Rocky G Gogliotti; Katharina A Quinlan; Courtenay B Barlow; Christopher R Heier; C J Heckman; Christine J Didonato
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

2.  Partial restoration of cardio-vascular defects in a rescued severe model of spinal muscular atrophy.

Authors:  Monir Shababi; Javad Habibi; Lixin Ma; Jacqueline J Glascock; James R Sowers; Christian L Lorson
Journal:  J Mol Cell Cardiol       Date:  2012-01-17       Impact factor: 5.000

Review 3.  Developing therapies for spinal muscular atrophy.

Authors:  Mary H Wertz; Mustafa Sahin
Journal:  Ann N Y Acad Sci       Date:  2015-07-14       Impact factor: 5.691

4.  Antisense oligonucleotides and spinal muscular atrophy: skipping along.

Authors:  Arthur H M Burghes; Vicki L McGovern
Journal:  Genes Dev       Date:  2010-08-01       Impact factor: 11.361

5.  Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model.

Authors:  Yimin Hua; Kentaro Sahashi; Gene Hung; Frank Rigo; Marco A Passini; C Frank Bennett; Adrian R Krainer
Journal:  Genes Dev       Date:  2010-07-12       Impact factor: 11.361

6.  Characterization of behavioral and neuromuscular junction phenotypes in a novel allelic series of SMA mouse models.

Authors:  Melissa Osborne; Daniel Gomez; Zhihua Feng; Corissa McEwen; Jose Beltran; Kim Cirillo; Bassem El-Khodor; Ming-Yi Lin; Yun Li; Wendy M Knowlton; David D McKemy; Laurent Bogdanik; Katherine Butts-Dehm; Kimberly Martens; Crystal Davis; Rosalinda Doty; Keegan Wardwell; Afshin Ghavami; Dione Kobayashi; Chien-Ping Ko; Sylvie Ramboz; Cathleen Lutz
Journal:  Hum Mol Genet       Date:  2012-07-16       Impact factor: 6.150

7.  Fetal Gene Therapy Using a Single Injection of Recombinant AAV9 Rescued SMA Phenotype in Mice.

Authors:  Afrooz Rashnonejad; Gholamhossein Amini Chermahini; Cumhur Gündüz; Hüseyin Onay; Ayça Aykut; Burak Durmaz; Meral Baka; Qin Su; Guangping Gao; Ferda Özkınay
Journal:  Mol Ther       Date:  2019-08-31       Impact factor: 11.454

8.  Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy.

Authors:  Suzan M Hammond; Gareth Hazell; Fazel Shabanpoor; Amer F Saleh; Melissa Bowerman; James N Sleigh; Katharina E Meijboom; Haiyan Zhou; Francesco Muntoni; Kevin Talbot; Michael J Gait; Matthew J A Wood
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

9.  The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.

Authors:  W Arnold; Vicki L McGovern; Benjamin Sanchez; Jia Li; Kaitlyn M Corlett; Stephen J Kolb; Seward B Rutkove; Arthur H Burghes
Journal:  Neurobiol Dis       Date:  2015-12-28       Impact factor: 5.996

Review 10.  Spinal muscular atrophy: a motor neuron disorder or a multi-organ disease?

Authors:  Monir Shababi; Christian L Lorson; Sabine S Rudnik-Schöneborn
Journal:  J Anat       Date:  2013-07-22       Impact factor: 2.610
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.